Crohn’s news round up 31st July 2011: Pharma news and win a trip to las Vegas!

IBD Icons launched

American Idol star Casey Abrams is promoting understanding of crohn’s and Colitis as well as offering a fantatsic prize for the ‘IBD icon’ of the year. Read more here:

Remicade/Infliximab has been FDA Approved for use in children. The  FDA advisory panel has recommended expanding the indication for infliximab (Remicade) to include treatment of ulcerative colitis in children. Infliximab, a tumor necrosis factor (TNF) inhibitor, is already approved to treat ulcerative colitis in adults and is also approved to treat Crohn’s disease in both adults and children. Read more here:

Lonza wins contract for bertilimumab(how on earth do you pronounce that?!!!)

Lonza has won a contract to manufacture Immune Pharmaceuticals’ antibody-based drug for inflammatory disorders, bertilimumab, at its mammalian development and manufacturing facility in the UK.

The deal will see the Swiss CMO produce clinical supplies of the antibody in it’s centre in Milton Keynes. Bertilimumab is just about to start a phase II trials programme in inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis.

Bertilimumab is the first monoclonal antibody to specifically neutralise human eotaxin-1, a chemokine associated with inflammatory disease activity.

Read more here:


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s